Sage Journals: Discover world-class research

Open access

Research article

First published 2021

COVID-19 in breast cancer patients: a subanalysis of the OnCovid registry

Laia Garrigós, Cristina Saura, Clara Martinez-Vila [...]

Therapeutic Advances in Medical Oncology

Open access

Research article

First published 2024

Impact of SARS-CoV-2 vaccines and recent chemotherapy on COVID-19 morbidity and mortality in patients with soft tissue sarcoma: an analysis from the OnCovid registry

Bruno Vincenzi, Alessio Cortellini, Alessandro Mazzocca [...]

Therapeutic Advances in Medical Oncology

Retricted access

Review article

First published 2025-10

Oncoviral Infection and the Significance of Reactive Oxygen Species: From Mechanisms to Therapeutic Significance

Ruixue Sang, Xia Zhao, Ketao Sun [...]

Antioxidants & Redox Signaling

Retricted access

Other

First published 2002-1

Cyclophosphamide,Hydroxydaunomycin (Doxorubicin),Oncovin (Vincristine),and Prednisone (CHOP) Regimen for Advanced Non-Hodgkin's Lymphomas

Matthew R. Rutledge, Dominic A. Solimando, J. Aubrey Waddell

Hospital Pharmacy

Retricted access

Other

First published 2002-2

Rituximab plus Cyclophosphamide,Hydroxydaunomycin (Doxorubicin),Oncovin (Vincristine),and Prednisone (R-CHOP) Regimen for Non-Hodgkin's Lymphomas

J. Aubrey Waddell, Dominic A. Solimando

Hospital Pharmacy

Retricted access

Research article

First published 2011-2

CODOX-M/IVAC for non-Hodgkin Lymphomas

Amanda Zomp, Dominic A. Solimando, J. Aubrey Waddell

Hospital Pharmacy

Open access

Research article

First published 2021

Specialist palliative and end-of-life care for patients with cancer and SARS-CoV-2 infection: a European perspective

Gehan Soosaipillai, Anjui Wu, Gino M Dettorre [...]

Therapeutic Advances in Medical Oncology

Search results

COVID-19 in breast cancer patients: a subanalysis of the OnCovid registry

Impact of SARS-CoV-2 vaccines and recent chemotherapy on COVID-19 morbidity and mortality in patients with soft tissue sarcoma: an analysis from the OnCovid registry

Oncoviral Infection and the Significance of Reactive Oxygen Species: From Mechanisms to Therapeutic Significance

Cyclophosphamide,Hydroxydaunomycin (Doxorubicin),Oncovin (Vincristine),and Prednisone (CHOP) Regimen for Advanced Non-Hodgkin's Lymphomas

Rituximab plus Cyclophosphamide,Hydroxydaunomycin (Doxorubicin),Oncovin (Vincristine),and Prednisone (R-CHOP) Regimen for Non-Hodgkin's Lymphomas

CODOX-M/IVAC for non-Hodgkin Lymphomas

Specialist palliative and end-of-life care for patients with cancer and SARS-CoV-2 infection: a European perspective